This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Pfizer Corporation, Raqualia Pharma Inc.. Active years: 2004-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Aichi-Ken, JP (2004 - 2006)
- Aichi, JP (2006)
- Chita-gun, JP (2009)
- Nagoya, JP (2011)
Company Filing History:
Years Active: 2004-2011
Title: Kana Taniguchi: Innovator in Prostaglandin Research
Introduction
Kana Taniguchi from Aichi-ken, Japan, is a distinguished inventor known for her contributions to the field of pharmaceuticals. With five patents to her name, she has made significant strides in understanding and treating diseases related to IL-6 and inflammation.
Latest Patents
Her most recent patents showcase innovative methods and compounds aimed at addressing IL-6 involved diseases. One patent focuses on the "Use of EP4 receptor ligands in the treatment of IL-6 involved diseases," introducing methods that utilize EP4 receptor antagonists. Another groundbreaking invention revolves around "Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents." This invention details compounds that can effectively treat medical conditions mediated by prostaglandin, targeting ailments such as pain, fever, and inflammation.
Career Highlights
Kana Taniguchi has an impressive professional background, having worked with reputable companies in the pharmaceutical industry, including Pfizer Corporation and Raqualia Pharma Inc. Her innovative work in drug development and her patents reflect her commitment to advancing medical science and improving patient care.
Collaborations
Throughout her career, Kana has collaborated with talented colleagues, including Kazunari Nakao and Yoshiyuki Okumura. These collaborations have enriched her research and have been pivotal in driving forward the development of her patented inventions.
Conclusion
Kana Taniguchi stands out as a prominent inventor in the pharmaceutical field, with her patents reflecting her dedication to tackling significant health issues. Her work on EP4 receptor ligands and anti-inflammatory compounds showcases her innovative spirit and commitment to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile